Jul 15 |
Andreas Halvorsen's Strategic Acquisition in Longboard Pharmaceuticals
|
Jul 9 |
Wall Street Analysts Think Longboard Pharmaceuticals (LBPH) Could Surge 43.7%: Read This Before Placing a Bet
|
Jul 9 |
Longboard Pharmaceuticals (LBPH) is on the Move, Here's Why the Trend Could be Sustainable
|
Jul 3 |
Top 3 Health Care Stocks That May Crash This Quarter
|
Jul 2 |
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
|
Jul 1 |
Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
|
Jun 10 |
Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
|
May 7 |
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans
|
May 4 |
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
|
May 3 |
Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
|